Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mannatech, Incorporated (MTEX:NASDAQ), powered by AI.
Mannatech, Incorporated is currently trading at $5.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mannatech, Incorporated on Alpha Lenz.
Mannatech, Incorporated's P/E ratio is -0.7.
“Mannatech, Incorporated trades at a P/E of -0.7 (undervalued) with modest ROE of -897.3%.”
Ask for details →Mannatech, Incorporated is a global health and wellness company that develops, markets, and distributes nutritional supplements, topical and skin care products, as well as weight-management solutions. The firm's core objective is to improve health and wellness through scientifically validated ingredients and formulas. Central to Mannatech's offerings are glyconutrient products, designed to support cellular communication within the body. Operating primarily in the multilevel marketing sector, it expands its reach by establishing direct sales channels across numerous international markets. Headquartered in Flower Mound, Texas, the company plays a significant role in the growing nutraceutical industry, meeting the increasing consumer demand for personalized health and wellness products. By leveraging cutting-edge research and development, Mannatech has positioned itself as a significant player in the global shift towards natural and holistic health solutions. With a focus on innovative product development and strategic market positioning, Mannatech addresses the needs of its diverse customer base, contributing to the broader trends in consumer healthcare and wellness products globally.
“Mannatech, Incorporated trades at a P/E of -0.7 (undervalued) with modest ROE of -897.3%.”
Ask for details →Mannatech, Incorporated (ticker: MTEX) is a company listed on NASDAQ in the Consumer Defensive sector (Food Distribution). It has approximately 189 employees. Market cap is $10M.
The current price is $5.5 with a P/E ratio of -0.69x and P/B of -2x.
ROE is -897.26% and operating margin is -0.39%. Annual revenue is $108M.